Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non‐demented individuals

L Lorenzini, LE Collij, N Tesi… - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION Unraveling how Alzheimer's disease (AD) genetic risk is related to
neuropathological heterogeneity, and whether this occurs through specific biological …

[PDF][PDF] Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals

N Vilor-Tejedor, S Ingala, K Blennow, C Foley… - 2024 - pure.ed.ac.uk
INTRODUCTION: Unraveling how Alzheimer's disease (AD) genetic risk is related to
neuropathological heterogeneity, and whether this occurs through specific biological …

[PDF][PDF] Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals

N Vilor-Tejedor, S Ingala, K Blennow, C Foley… - 2024 - pure.tudelft.nl
INTRODUCTION: Unraveling how Alzheimer's disease (AD) genetic risk is related to
neuropathological heterogeneity, and whether this occurs through specific biological …

Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals

L Lorenzini, LE Collij, N Tesi… - … & dementia: the … - pubmed.ncbi.nlm.nih.gov
Introduction Unraveling how Alzheimer's disease (AD) genetic risk is related to
neuropathological heterogeneity, and whether this occurs through specific biological …

Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non‐demented individuals

L Lorenzini, LE Collij, N Tesi, N Vilor‐Tejedor, S Ingala… - 2024 - repository.cam.ac.uk
Abstract jats: titleAbstract</jats: title> jats: secjats: titleINTRODUCTION</jats: title> jats:
pUnraveling how Alzheimer's disease (AD) genetic risk is related to neuropathological …

Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non‐demented individuals

L Lorenzini, N Tesi, N Vilor‐tejedor… - … & Dementia: The …, 2024 - research.ed.ac.uk
INTRODUCTION: Unraveling how Alzheimer's disease (AD) genetic risk is related to
neuropathological heterogeneity, and whether this occurs through specific biological …

Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals

L Lorenzini, LE Collij, N Tesi… - Alzheimer's & …, 2024 - cris.maastrichtuniversity.nl
INTRODUCTION: Unraveling how Alzheimer's disease (AD) genetic risk is related to
neuropathological heterogeneity, and whether this occurs through specific biological …

Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals

L Lorenzini, LE Collij, N Tesi… - Alzheimer's and …, 2024 - research.tudelft.nl
Methods We computed pathway-specific genetic risk scores (GRSs) in non-demented
individuals and investigated how AD risk variants predict cerebrospinal fluid (CSF) and …

Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals

L Lorenzini, LE Collij, N Tesi… - … & dementia: the …, 2024 - research.regionh.dk
INTRODUCTION: Unraveling how Alzheimer's disease (AD) genetic risk is related to
neuropathological heterogeneity, and whether this occurs through specific biological …